The effect of Aspirin in prevention of pre eclampcia and its complication in women with abnormal uteirn Artery Doppler ultrasound
Not Applicable
- Conditions
- preeclampsia.Pre-eclampsia, unspecified
- Registration Number
- IRCT138809232854N1
- Lead Sponsor
- Vice Chancellor of resarch
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- Female
- Target Recruitment
- 80
Inclusion Criteria
inclusion criteria:
pregnant women in 16-18 week with preeclampsia risk such as: vascular diseas,chronic hypertension, diabet melitus, age under 20 and more than 40 years old.
Exclusion criteria: women with heart disease, liver disease, thyroid disease, chronic renal disease and peptic ulcer.
Exclusion Criteria
Not provided
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method In prevention of pre eclampcia and its complication in women with abnormal uteirn Artery Doppler ultrasound. Timepoint: every two weeks. Method of measurement: patient visit and blood presure chek.
- Secondary Outcome Measures
Name Time Method Delivery type. Timepoint: after delivery. Method of measurement: Documented data.;Preterm labor. Timepoint: after delivery. Method of measurement: documented data.;Neonatal Apgar score. Timepoint: 1 and 5 minute after delivery. Method of measurement: heart rate, respiratory rate, tone,skin color and grimace.;Neonatal weight. Timepoint: after delivery. Method of measurement: neonatal weight asses.;Intra uterine Growth Restriction. Timepoint: after delivery. Method of measurement: based on age and weight.